Advertisement
American Journal of Health-System Pharmacy, Vol. 67, Issue 2, 148-152
Copyright © 2010 by American Society of Health-System Pharmacists
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Robke, J. T.
Right arrow Articles by Woods, M.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Robke, J. T.
Right arrow Articles by Woods, M.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Case Study

A decade of experience with an inpatient pneumococcal vaccination program

 Jill True Robke and Mark Woods

JILL TRUE ROBKE, PHARM.D., BCPS, FASHP, is Clinical Pharmacy Specialist; and MARK WOODS, PHARM.D., FASHP, BCPS, is Clinical Coordinator and Residency Program Director, Saint Luke’s Hospital of Kansas City, Kansas City, MO

Address correspondence to Dr. Robke at the Saint Luke’s Hospital of Kansas City, 4401 Wornall Road, Kansas City, MO 64111 (jrobke{at}saint-lukes.org).


Purpose. A hospital’s experience with an inpatient pneumococcal vaccination program is described.

Summary. Saint Luke’s Hospital (SLH) is a 625-bed, tertiary care, referral hospital in Kansas City, Missouri. In a retrospective analysis conducted in 1995 of pneumococcal vaccination rates in patients with community-acquired pneumonia (CAP) at the hospital, only 1 of 84 patients had documented pneumococcal vaccination. These results led to efforts to improve assessment of vaccination status, documentation of vaccination, and pneumococcal vaccination rates. In 1998, the pharmacy department at SLH conducted a study to examine the impact of pharmacists on pneumococcal vaccination rates through incorporation of vaccination assessment into selected critical pathways. Pharmacists were assigned to screen and educate patients on chosen pathways. When eligible patients were identified in the intervention group, the pharmacist would then contact their physician for authorization to vaccinate. The success of the study led to several notable changes to the pneumococcal vaccination program in 2001. First, the vaccination assessment was moved from selected critical pathways to the admission database of all patients. Second, a collaborative practice agreement was developed to authorize pharmacists to write pneumococcal and influenza vaccine orders for eligible patients per the program’s protocol. These two changes led to a dramatic improvement in overall screening and documentation rates of pneumococcal vaccination for patients with CAP and for other at-risk patients.

Conclusion. A pneumococcal vaccination program helped a hospital meet regulatory expectations for vaccination of patients with CAP and vaccinated many other at-risk patients.

Index terms: Documentation; Hospitals; Immunization; Pharmaceutical services; Pharmacists; hospital; Pharmacy; institutional; hospital; Pneumococcal infections; Pneumococcal vaccines; Pneumonia; Vaccines

 

Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?